Many of the compounds promoted online have never passed through the clinical trials required to establish a drugs dose, benefits and risks
European Heart Journal - Cardiovascular Pharmacotherapy 10(4):296306 Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
These are research-context interests, not validated clinical outcomes
However, if your provider sees a red flag in your intake, like possible thyroid issues, elevated blood sugar, or a history of liver disease, you may be asked to complete lab work before starting medication
Most experienced researchers use both methods
If high concentrations of the drug are harmful, individuals with renal impairment would be at risk for heart complications as they would be exposed to such concentrations for an extended period of time, given Bydureons naturally long duration of action and their bodys inability to remove the drug fast enough